Eastern Bank’s Solid Biosciences SLDB Stock Holding History

Eastern Bank’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.09K	Hold	151	–	–	﹤0.01%	1062
2026 Q2	$1.51K	Buy	+151	New	+$1.14K	﹤0.01%	982

Other funds holding SLDB

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Eastern Bank's SLDB Position: Q3 2026 in Review

Eastern Bank held its Solid Biosciences (SLDB) position steady in Q3 2026 at 151 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #1062.

Eastern Bank first reported a position in SLDB in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.51K in Q2 2026. 9 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.

Eastern Bank held 151 shares of Solid Biosciences worth $1.09K as of Q3 2026.
Eastern Bank left its Solid Biosciences share count unchanged in Q3 2026.
Solid Biosciences made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #1062 holding.
Eastern Bank first reported a position in Solid Biosciences in Q2 2026 and has held it in 2 quarters since.
Eastern Bank's Solid Biosciences position peaked at $1.51K in Q2 2026.
9 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.